Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 298
6
Diseases
37
Unique genes
0.098
Avg. similarity score
Congenital hydrocephalus
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Congenital hydrocephalus
Hydrocephalus
Congenital communicating hydrocephalus
Cryptospermia
SMARCC1-associated developmental dysgenesis syndrome
scott syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Congenital hydrocephalus | 5 | 5 | 14 |
| Hydrocephalus | 4 | 4 | 26 |
| Congenital communicating hydrocephalus | 3 | 3 | 3 |
| Cryptospermia | 3 | 3 | 4 |
| SMARCC1-associated developmental dysgenesis syndrome | 2 | 2 | 1 |
| scott syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TRIM71 | 4 / 6 | Congenital communicating hydrocephalus, Congenital hydrocephalus, Cryptospermia, Hydrocephalus |
| MPDZ | 3 / 6 | Congenital communicating hydrocephalus, Congenital hydrocephalus, Hydrocephalus |
| SMARCC1 | 3 / 6 | Congenital hydrocephalus, Hydrocephalus, SMARCC1-associated developmental dysgenesis syndrome |
| WDR81 | 3 / 6 | Congenital communicating hydrocephalus, Congenital hydrocephalus, Hydrocephalus |
| ANO6 | 2 / 6 | Congenital hydrocephalus, scott syndrome |
| CCDC88C | 2 / 6 | Congenital hydrocephalus, Hydrocephalus |
| L1CAM | 2 / 6 | Congenital hydrocephalus, Hydrocephalus |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Mannose type O-glycan biosynthesis | KEGG | 2 / 23 | 28.2× | 2.24e-3 | 2.48e-2 ✓ sig. |
| Signaling by FGFR2 amplification mutants | Reactome | 1 / 1 | 325× | 3.08e-3 | 3.13e-2 ✓ sig. |
| Signaling by FGFR2 fusions | Reactome | 1 / 1 | 325× | 3.08e-3 | 3.13e-2 ✓ sig. |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | Reactome | 1 / 2 | 162× | 6.15e-3 | 5.02e-2 |
| Recycling pathway of L1 | Reactome | 2 / 40 | 16.2× | 6.69e-3 | 5.30e-2 |
| Loss of MECP2 binding ability to 5mC-DNA | Reactome | 1 / 3 | 108× | 9.21e-3 | 6.53e-2 |
| L1CAM interactions | Reactome | 1 / 4 | 81.1× | 1.23e-2 | 7.74e-2 |
| Hedgehog signaling pathway | KEGG | 2 / 56 | 11.6× | 1.28e-2 | 7.92e-2 |
| Hedgehog 'off' state | Reactome | 2 / 56 | 11.6× | 1.28e-2 | 7.92e-2 |
| MicroRNAs in cancer | KEGG | 4 / 311 | 4.2× | 1.49e-2 | 8.66e-2 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | Reactome | 1 / 5 | 64.9× | 1.53e-2 | 8.81e-2 |
| Basal cell carcinoma | KEGG | 2 / 63 | 10.3× | 1.60e-2 | 9.07e-2 |
| Wnt signaling pathway | KEGG | 3 / 174 | 5.6× | 1.62e-2 | 9.12e-2 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | Reactome | 1 / 6 | 54.1× | 1.83e-2 | 9.81e-2 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | Reactome | 1 / 6 | 54.1× | 1.83e-2 | 9.81e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| neural tube closure | GO:0001843 | 4 / 85 | 23.8× | 2.35e-5 | 1.01e-3 ✓ sig. |
| cilium movement | GO:0003341 | 3 / 48 | 31.6× | 1.16e-4 | 3.39e-3 ✓ sig. |
| animal organ morphogenesis | GO:0009887 | 4 / 130 | 15.5× | 1.24e-4 | 3.55e-3 ✓ sig. |
| mucociliary clearance | GO:0120197 | 2 / 12 | 84.2× | 2.49e-4 | 5.90e-3 ✓ sig. |
| commissural neuron axon guidance | GO:0071679 | 2 / 14 | 72.2× | 3.42e-4 | 7.34e-3 ✓ sig. |
| prostate gland development | GO:0030850 | 2 / 16 | 63.1× | 4.50e-4 | 8.90e-3 ✓ sig. |
| protein O-linked glycosylation via mannose | GO:0035269 | 2 / 18 | 56.1× | 5.72e-4 | 1.05e-2 ✓ sig. |
| female gamete generation | GO:0007292 | 2 / 21 | 48.1× | 7.82e-4 | 1.29e-2 ✓ sig. |
| negative regulation of keratinocyte proliferation | GO:0010839 | 2 / 24 | 42.1× | 1.02e-3 | 1.53e-2 ✓ sig. |
| basement membrane organization | GO:0071711 | 2 / 29 | 34.8× | 1.50e-3 | 1.91e-2 ✓ sig. |
| regulation of smoothened signaling pathway | GO:0008589 | 2 / 29 | 34.8× | 1.50e-3 | 1.91e-2 ✓ sig. |
| non-canonical Wnt signaling pathway | GO:0035567 | 2 / 33 | 30.6× | 1.94e-3 | 2.21e-2 ✓ sig. |
| response to methylglyoxal | GO:0051595 | 1 / 1 | 505× | 1.98e-3 | 2.24e-2 ✓ sig. |
| cellular response to tert-butyl hydroperoxide | GO:0072736 | 1 / 1 | 505× | 1.98e-3 | 2.24e-2 ✓ sig. |
| phosphatidylserine exposure on blood platelet | GO:0097045 | 1 / 1 | 505× | 1.98e-3 | 2.24e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Congenital hydrocephalus | Hydrocephalus | 0.171 | 6 | 3.71e-14 | 5.24e-13 ✓ sig. |
| Congenital communicating hydrocephalus | Congenital hydrocephalus | 0.200 | 3 | 5.98e-10 | 5.84e-9 ✓ sig. |
| Congenital communicating hydrocephalus | Hydrocephalus | 0.111 | 3 | 4.27e-9 | 3.84e-8 ✓ sig. |
| Congenital communicating hydrocephalus | Cryptospermia | 0.143 | 1 | 7.79e-4 | 1.39e-3 ✓ sig. |
| Congenital hydrocephalus | SMARCC1-associated developmental dysgenesis syndrome | 0.067 | 1 | 9.09e-4 | 1.56e-3 ✓ sig. |
| Congenital hydrocephalus | scott syndrome | 0.067 | 1 | 9.09e-4 | 1.56e-3 ✓ sig. |
| Hydrocephalus | SMARCC1-associated developmental dysgenesis syndrome | 0.037 | 1 | 1.69e-3 | 2.51e-3 ✓ sig. |
| Congenital hydrocephalus | Cryptospermia | 0.056 | 1 | 3.63e-3 | 4.66e-3 ✓ sig. |
| Cryptospermia | Hydrocephalus | 0.033 | 1 | 6.74e-3 | 8.02e-3 ✓ sig. |